We are live on ! Find out more
CPIX icon

Cumberland Pharmaceuticals
CPIX

48 hedge funds and large institutions have $23.2M invested in Cumberland Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 12 increasing their positions, 15 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

2% more funds holding

Funds holding: 47 → 48 (+1)

14% less capital invested

Capital invested by funds: $27M → $23.2M (-$3.78M)

20% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 15

Holders
48
Holders Change
+1
Holders Change %
+2.13%
% of All Funds
1.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
12
Reduced
15
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AI
Ariel Investments
Illinois
+$2.67M
2
BCM
Bridgeway Capital Management
Texas
+$715K
3
New York State Common Retirement Fund
New York State Common Retirement Fund
New York
+$368K
4
Northern Trust
Northern Trust
Illinois
+$77.1K
5
CCM
Coldstream Capital Management
Washington
+$74.7K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$3.23M
2
SLG
Stanley-Laman Group
Pennsylvania
-$216K
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$155K
4
BIT
BlackRock Institutional Trust
California
-$94K
5
TDC
Thompson Davis & Co
Virginia
-$78.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
JAM
26
JW Asset Management
Florida
$49K – – –
Cambridge Investment Research Advisors
27
Cambridge Investment Research Advisors
Iowa
$45K – – –
RFC
28
Russell Frank Company
Washington
$23K – – –
BA
29
BlackRock Advisors
Delaware
$20K – – –
NFA
30
Nationwide Fund Advisors
Ohio
$17K – – –
OC
31
Oakworth Capital
Alabama
$14K – – –
PNC Financial Services Group
32
PNC Financial Services Group
Pennsylvania
$14K – – –
Walleye Trading
33
Walleye Trading
New York
$13K +$3.33K +700 +33%
BIM
34
BlackRock Investment Management
Delaware
$9K – – –
WIC
35
Woodmont Investment Counsel
Tennessee
$9K – – –
OSAM
36
O'Shaughnessy Asset Management
Connecticut
$8K -$1.47K -309 -15%
TRCT
37
Tower Research Capital (TRC)
New York
$8K +$4.82K +1,011 +137%
Citigroup
38
Citigroup
New York
$5K – – –
Deutsche Bank
39
Deutsche Bank
Germany
$4K +$758 +159 +20%
MA
40
MUFG Americas
New York
$3K -$2.33K -490 -41%
Manulife (Manufacturers Life Insurance)
41
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$3K – – –
UMA
42
USA Mutuals Advisors
Texas
$3K – – –
UBS Group
43
UBS Group
Switzerland
$3K +$1.09K +228 +41%
TDC
44
Thompson Davis & Co
Virginia
$1K -$78.4K -16,450 -99%
SEI Investments
45
SEI Investments
Pennsylvania
$1K +$615 +129 +103%
Geode Capital Management
46
Geode Capital Management
Massachusetts
$216 -$376 -79 -0.2%
Millennium Management
47
Millennium Management
New York
– -$3.23M -614,092 Closed
1
2

CPIX Hedge Fund Activity: Q1 2016 in Review

48 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q1 2016, worth a combined $23.2M — down 14% from $27M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new CPIX positions and 1 closed out — a net gain of 1 holder — while 12 added to existing stakes and 15 trimmed.

The largest buyer was Ariel Investments, adding an estimated $2.67M. The largest seller was Millennium Management, exiting entirely with an estimated $3.23M sold.

  • 48 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q1 2016, up from 47 in Q4 2015.
  • Funds reported $23.2M of Cumberland Pharmaceuticals stock for Q1 2016, down 14% quarter-over-quarter.
  • 2 funds opened new Cumberland Pharmaceuticals positions in Q1 2016 and 1 closed out, a net change of +1 holder.
  • The largest Cumberland Pharmaceuticals buyer in Q1 2016 was Ariel Investments, an estimated $2.67M added.
  • The largest Cumberland Pharmaceuticals seller in Q1 2016 was Millennium Management, an estimated $3.23M sold.

Based on aggregated 13F filings for Q1 2016.